•
Dec 31, 2020

Zynex Q4 2020 Earnings Report

Reported highest quarterly revenue and positive net income for the eighteenth consecutive quarter.

Key Takeaways

Zynex reported an 81% increase in net revenue to $25.6 million and a net income of $1.8 million for the fourth quarter of 2020. Orders grew 117% compared to Q4 2019.

Net revenue increased by 81% compared to the fourth quarter of 2019.

Gross margins were 78% in the fourth quarter of 2020.

Net income was $1.8 million.

Orders grew 117% compared to the fourth quarter of 2019.

Total Revenue
$25.6M
Previous year: $14.2M
+80.8%
EPS
$0.05
Previous year: $0.08
-37.5%
Gross Profit
$0
Previous year: $11.4M
-100.0%
Cash and Equivalents
$39.2M
Previous year: $14M
+180.0%
Free Cash Flow
-$1.92M
Previous year: $2.07M
-192.9%
Total Assets
$72.2M
Previous year: $28.3M
+155.2%

Zynex

Zynex

Forward Guidance

Full year 2021 revenue is estimated between $135.0 and $150.0 million with Adjusted EBITDA between $15.0 and $25.0 million. The revenue estimate for Q1 is approximately 51% to 61% above 2020 first quarter revenue of $15.2 million.

Positive Outlook

  • Full year 2021 revenue is estimated between $135.0 and $150.0 million
  • Adjusted EBITDA between $15.0 and $25.0 million for full year 2021
  • Full year revenue estimate is approximately 68% to 87% above 2020 revenue of $80.1 million.
  • Revenue estimate for Q1 is approximately 51% to 61% above 2020 first quarter revenue of $15.2 million.

Challenges Ahead

  • Adjusted EBITDA loss of between $0.5 and $1.5 million for Q1
  • First quarter revenue is historically affected by health insurance deductibles not being met in the beginning of the year.
  • Seasonality of deductibles affects Q1
  • Slower ramping of sales orders due to COVID-19 restrictions are factors which will produce a small loss in Q1.